Clinical Trial Update: Effect of Serum Vitamin D Level on the Efficacy of Peg-interferon Treatment in CHB [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating whether baseline serum vitamin D levels influence the efficacy of pegylated interferon in chronic hepatitis B.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Peg-interferon (pegylated interferon alfa)

Snippet

Sponsor: Third Affiliated Hospital, Sun Yat-Sen University | Conditions: Chronic Hepatitis b | Phase 4 | Status: COMPLETED